Christina is a leader at GRAIL specializing in the development and commercialization of blood-based multi-cancer detection (MCD) products. She designs and executes large-scale studies to support the value of MCD tests leveraging expertise in population health and cancer registries. With over 190 scientific publications and an h-index of 81 she co-chairs the BloodPAC Working Group. Christina integrates epidemiology genomics and public health to improve cancer detection and health outcomes.
666 3rd Ave, 6th Floor, New York, NY 10017